Cargando…

Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial

Background: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease in the world. The current interventional trial aimed to evaluate the effects of supplementation with oleoylethanolamide (OEA) in combination with weight loss intervention on some atherogenic ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tutunchi, Helda, Naeini, Fatemeh, Saghafi-Asl, Maryam, Farrin, Nazila, Monshikarimi, Alireza, Ostadrahimi, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722997/ https://www.ncbi.nlm.nih.gov/pubmed/33312933 http://dx.doi.org/10.34172/hpp.2020.56

Ejemplares similares

Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Tutunchi, Helda, et al.
Publicado: (2020)

Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial
por: Akbari, Neda, et al.
Publicado: (2022)

Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial
por: Tutunchi, Helda, et al.
Publicado: (2023)

The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults
por: Tutunchi, Helda, et al.
Publicado: (2020)

Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
por: Ghaffari, Samad, et al.
Publicado: (2020)

What hematological and endocrinal indicators are important in COVID-19 infection?
por: Ostadrahimi, Alireza, et al.
Publicado: (2022)

Is the modified household food security survey (HFSS) questionnaire a practical tool for screening food insecurity? Evidence from northwest of Iran
por: Tutunchi, Helda, et al.
Publicado: (2020)

Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial
por: Payahoo, Laleh, et al.
Publicado: (2018)

What are the optimal cut-off points of anthropometric indices for prediction of overweight and obesity? Predictive validity of waist circumference, waist-to-hip and waist-to-height ratios
por: Tutunchi, Helda, et al.
Publicado: (2020)

Vanadium and biomarkers of inflammation and oxidative stress in diabetes: A systematic review of animal studies
por: Ghalichi, Faezeh, et al.
Publicado: (2022)

Nutrition interventions to address nutritional problems in HIV-positive patients: translating knowledge into practice
por: Rezazadeh, Leila, et al.
Publicado: (2023)

Saffron (Crocus sativus L.) supplements improve quality of life and appetite in atherosclerosis patients: A randomized clinical trial
por: Ahmadikhatir, Shonaz, et al.
Publicado: (2022)

Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Associations between Lake Urmia disaster and the prevalence of thyroid nodules and metabolic syndrome: The AZAR cohort survey
por: Houshyar, Jalil, et al.
Publicado: (2022)

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
por: Badali, Taghi, et al.
Publicado: (2023)

Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism
por: Ostadrahimi, Alireza, et al.
Publicado: (2023)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
por: Naeini, Fatemeh, et al.
Publicado: (2021)

Yogurt consumption and risk of mortality from all causes, CVD and cancer: a comprehensive systematic review and dose–response meta-analysis of cohort studies
por: Tutunchi, Helda, et al.
Publicado: (2023)

Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review
por: Mahluji, Sepideh, et al.
Publicado: (2021)

Dietary linoleic acid intake in relation to breast cancer: A case-control study
por: Joya, Muhammad Reza, et al.
Publicado: (2023)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet
por: Tutunchi, Helda, et al.
Publicado: (2023)

Effect of Probiotic Fermented Milk (Kefir) on Glycemic Control and Lipid Profile In Type 2 Diabetic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial
por: OSTADRAHIMI, Alireza, et al.
Publicado: (2015)

Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals
por: Ebrahimzadeh-Attari, Vahideh, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
por: Roshanravan, Neda, et al.
Publicado: (2022)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021)

The effect of n-3 long chain fatty acids supplementation on plasma peroxisome proliferator activated receptor gamma and thyroid hormones in obesity
por: Taraghijou, Parizad, et al.
Publicado: (2012)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

Effect of Oleoylethanolamide-Based Dietary Supplement on Systemic Inflammation in the Development of Alimentary-Induced Obesity in Mice
por: Ivashkevich, Darya, et al.
Publicado: (2023)

Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
por: De Filippo, Carlotta, et al.
Publicado: (2023)

Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease
por: Peng, Hewei, et al.
Publicado: (2023)

Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults
por: Saghafi, Samira, et al.
Publicado: (2023)

Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial
por: Pouryousefi, Elahe, et al.
Publicado: (2022)

Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
por: Koethe, Dagmar, et al.
Publicado: (2009)

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL
por: Fan, Angran, et al.
Publicado: (2014)

Oleoylethanolamide‐induced anorexia in rats is associated with locomotor impairment
por: Fedele, Shahana, et al.
Publicado: (2018)

Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
por: Diao, Xiaotong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap26frv2hkdvmfb99lhe5bg9kk